These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25466863)

  • 1. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
    Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
    Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey.
    Eichholzer M; Richard A; Rohrmann S; Schmid S; Güth U
    Eur J Cancer Prev; 2016 Mar; 25(2):130-6. PubMed ID: 25793921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
    Sun L; Zhu Y; Qian Q; Tang L
    Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does obesity have an effect on outcomes in triple-negative breast cancer?
    Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
    J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Weighing in' on screening mammography.
    Berz D; Sikov W; Colvin G; Weitzen S
    Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, mammography use and accuracy, and advanced breast cancer risk.
    Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
    J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
    Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
    Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
    Scholz C; Andergassen U; Hepp P; Schindlbeck C; Friedl TW; Harbeck N; Kiechle M; Sommer H; Hauner H; Friese K; Rack B; Janni W
    Breast Cancer Res Treat; 2015 Jun; 151(3):569-76. PubMed ID: 25962694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
    Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
    J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index, diabetes, and triple-negative breast cancer prognosis.
    Tait S; Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
    Breast Cancer Res Treat; 2014 Jul; 146(1):189-97. PubMed ID: 24869799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Women's cancer screening according to Body Mass Index in a cohort of rural Korean women].
    Kim BH; Koh SB; Hur HK; Park JK; Park SM
    J Korean Acad Nurs; 2009 Oct; 39(5):641-50. PubMed ID: 19901494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of detection: an independent prognostic factor for women with breast cancer.
    Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
    J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.